Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials (Q33788475)

29 July 2017

1 reference

title

Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials (English)

1 reference

29 July 2017

irritable bowel syndrome

1 reference

Spiller RC

1

1 reference

PubMed ID

10588179

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Medicine

29 July 2017

1 reference

29 July 2017

107

1 reference

29 July 2017

91S-97S

1 reference

29 July 2017

5A

1 reference

Controlled treatment trials in the irritable bowel syndrome: a critique.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Effects of acute psychologic stress on small-intestinal motility in health and the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Steroid hormone abnormalities in women with severe idiopathic constipation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Loperamide treatment of the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Role of loperamide and placebo in management of irritable bowel syndrome (IBS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Double blind study of ispaghula in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Bran supplementation in the treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Ambulatory intestinal manometry: a consensus report on its clinical role.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Controlled study of psychotherapy in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Food intolerance and the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Hypnotherapy in severe irritable bowel syndrome: further experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Irritable bowel syndrome: a technical review for practice guideline development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Effects of desipramine on irritable bowel syndrome compared with atropine and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900086-8

10.1016/S0002-9343(99)00086-8

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10588179